These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9514829)

  • 1. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease.
    Thorns V; Hansen L; Masliah E
    Exp Neurol; 1998 Mar; 150(1):14-20. PubMed ID: 9514829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.
    Simic G; Lucassen PJ; Krsnik Z; Kruslin B; Kostovic I; Winblad B; Bogdanovi
    Exp Neurol; 2000 Sep; 165(1):12-26. PubMed ID: 10964481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of caspase-8 in the Alzheimer's disease brain.
    Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease.
    von Gunten A; Kövari E; Bussière T; Rivara CB; Gold G; Bouras C; Hof PR; Giannakopoulos P
    Neurobiol Aging; 2006 Feb; 27(2):270-7. PubMed ID: 16399212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of neuronal nitric oxide synthase-immunoreactive neurons in the mouse hippocampus with optical disector.
    Jinno S; Aika Y; Fukuda T; Kosaka T
    J Comp Neurol; 1999 Aug; 410(3):398-412. PubMed ID: 10404408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early involvement of small inhibitory cortical interneurons in Alzheimer's disease.
    Koliatsos VE; Kecojevic A; Troncoso JC; Gastard MC; Bennett DA; Schneider JA
    Acta Neuropathol; 2006 Aug; 112(2):147-62. PubMed ID: 16758165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field.
    von Gunten A; Kövari E; Rivara CB; Bouras C; Hof PR; Giannakopoulos P
    Exp Neurol; 2005 May; 193(1):198-206. PubMed ID: 15817278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between the neuronal nitric oxide synthase gene polymorphism and Alzheimer Disease.
    Liou YJ; Hong CJ; Liu HC; Liu CY; Liu TY; Chen IC; Tsai SJ
    Am J Med Genet; 2002 Aug; 114(6):687-8. PubMed ID: 12210288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain.
    Stepanichev MY; Onufriev MV; Yakovlev AA; Khrenov AI; Peregud DI; Vorontsova ON; Lazareva NA; Gulyaeva NV
    Neurochem Int; 2008 May; 52(6):1114-24. PubMed ID: 18207612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease.
    Fernández-Vizarra P; Fernández AP; Castro-Blanco S; Encinas JM; Serrano J; Bentura ML; Muñoz P; Martínez-Murillo R; Rodrigo J
    Neurobiol Dis; 2004 Mar; 15(2):287-305. PubMed ID: 15006699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat.
    Uttenthal LO; Alonso D; Fernández AP; Campbell RO; Moro MA; Leza JC; Lizasoain I; Esteban FJ; Barroso JB; Valderrama R; Pedrosa JA; Peinado MA; Serrano J; Richart A; Bentura ML; Santacana M; Martínez-Murillo R; Rodrigo J
    Microsc Res Tech; 1998 Oct; 43(1):75-88. PubMed ID: 9829462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.
    Norris PJ; Faull RL; Emson PC
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):36-49. PubMed ID: 8883932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.
    Lüth HJ; Ogunlade V; Kuhla B; Kientsch-Engel R; Stahl P; Webster J; Arendt T; Münch G
    Cereb Cortex; 2005 Feb; 15(2):211-20. PubMed ID: 15238435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of NADPH-diaphorase and expression of nNOS, N-methyl-D-aspartate receptor (NMDAR1) and non-NMDA glutamate receptor (GlutR2) genes in the neurons of the hippocampus after domoic acid-induced lesions in adult rats.
    Ananth C; Dheen ST; Gopalakrishnakone P; Kaur C
    Hippocampus; 2003; 13(2):260-72. PubMed ID: 12699333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.
    Chan-Palay V; Lang W; Haesler U; Köhler C; Yasargil G
    J Comp Neurol; 1986 Jun; 248(3):376-94. PubMed ID: 3522663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden.
    Jeynes B; Provias J
    Neurosci Lett; 2009 Oct; 463(3):244-8. PubMed ID: 19660523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
    Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.